Huazhong University of Science and Technology
4 clinical trials · 4 recruiting · OTHER
Trials by Huazhong University of Science and Technology
RECRUITINGNCT07463872
Management of Pancreatic Cystic Lesions Using Artificial Intelligence Based on EUS and Multimodal Data
The primary objective is to construct a multimodal AI model (Cyst-AI) based on EUS images and clinical data such as imaging features(CT or MRI) and laboratory tests to assist...
Sponsor: Huazhong University of Science and TechnologyEnrolling: 5002 locations
Pancreatic Cystic LesionMucinous Cystadenoma of PancreasIntraductal Papillary Mucinous Neoplasm of Pancreas+3
RECRUITINGPhase 2NCT06005870
Zanubrutinib Combined With R-CHOP in the Treatment of Newly Diagnosed DLBCL With p53 Protein Expression
This study aim to evaluate the efficacy and safety of zanubrutinib combined with R-CHOP in the treatment of DLBCL patients with p53 protein expression.
Sponsor: Huazhong University of Science and TechnologyEnrolling: 411 location
Diffuse Large B Cell Lymphoma
RECRUITINGPhase 4NCT07019012
Cofrogliptin Once Every 2 Weeks as Add-on Therapy to Metformin and Dapagliflozin Versus Daily Linagliptin in Patients...
This study is designed to evaluate the change in glycated hemoglobin (HbA1c) levels from baseline to 24 weeks after the combination therapy of cofrogliptin, metformin and SGLT2i...
Sponsor: Huazhong University of Science and TechnologyEnrolling: 1702 locations
T2DM
RECRUITINGNCT05448703
A Study on Predictive Models and Clinical Outcome of Radiation Pneumonitis
Radiation pneumonitis is the main dose-limiting toxicity of thoracic radiotherapy, which can affect life quality, survival, and the tumor-controlling effects of patients receiving...
Sponsor: Huazhong University of Science and TechnologyEnrolling: 3003 locations
Radiation Pneumonitis